VestGen Investment Management Increases Stake in UnitedHealth Group Incorporated $UNH

VestGen Investment Management boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 17.0% during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 723 shares of the healthcare conglomerate’s stock after purchasing an additional 105 shares during the quarter. VestGen Investment Management’s holdings in UnitedHealth Group were worth $226,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in UNH. Bayforest Capital Ltd boosted its holdings in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its holdings in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 50 shares during the last quarter. Glass Jacobson Investment Advisors llc boosted its holdings in shares of UnitedHealth Group by 80.9% in the second quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock worth $38,000 after buying an additional 55 shares during the last quarter. Kentucky Trust Co boosted its holdings in shares of UnitedHealth Group by 53.8% in the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock worth $45,000 after buying an additional 50 shares during the last quarter. Finally, O Brien Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after buying an additional 37 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Morgan Stanley raised their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Robert W. Baird reaffirmed an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Mizuho lifted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Finally, Piper Sandler lowered their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Eighteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $385.13.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $362.78 on Monday. The stock has a market cap of $328.56 billion, a price-to-earnings ratio of 15.72, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm has a 50-day moving average of $338.43 and a two-hundred day moving average of $335.78.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same period last year, the firm earned $6.80 earnings per share. UnitedHealth Group’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.